155 related articles for article (PubMed ID: 17011540)
1. Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay.
Rihs HP; John A; Scherenberg M; Seidel A; Brüning T
Clin Chim Acta; 2007 Feb; 376(1-2):240-3. PubMed ID: 17011540
[TBL] [Abstract][Full Text] [Related]
2. Re-investigation of the concordance of human NAT2 phenotypes and genotypes.
Bolt HM; Selinski S; Dannappel D; Blaszkewicz M; Golka K
Arch Toxicol; 2005 Apr; 79(4):196-200. PubMed ID: 15558239
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.
Jetter A; Kinzig-Schippers M; Illauer M; Hermann R; Erb K; Borlak J; Wolf H; Smith G; Cascorbi I; Sörgel F; Fuhr U
Eur J Clin Pharmacol; 2004 Mar; 60(1):17-21. PubMed ID: 14747882
[TBL] [Abstract][Full Text] [Related]
4. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.
Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E
J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937
[TBL] [Abstract][Full Text] [Related]
5. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
[TBL] [Abstract][Full Text] [Related]
6. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
[TBL] [Abstract][Full Text] [Related]
7. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
Lu JF; Yi T; Cao XM; Zhuo HT; Ling SS
Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199
[TBL] [Abstract][Full Text] [Related]
8. Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?
Jetter A; Kinzig M; Rodamer M; Tomalik-Scharte D; Sörgel F; Fuhr U
Eur J Clin Pharmacol; 2009 Apr; 65(4):411-7. PubMed ID: 19082994
[TBL] [Abstract][Full Text] [Related]
9. N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.
Aklillu E; Carrillo JA; Makonnen E; Bertilsson L; Djordjevic N
Eur J Clin Pharmacol; 2018 Jul; 74(7):903-911. PubMed ID: 29589062
[TBL] [Abstract][Full Text] [Related]
10. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
[TBL] [Abstract][Full Text] [Related]
11. NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.
Nyéki A; Buclin T; Biollaz J; Decosterd LA
Br J Clin Pharmacol; 2003 Jan; 55(1):62-7. PubMed ID: 12534641
[TBL] [Abstract][Full Text] [Related]
12. [The acetylator polymorphism in a Khmer population: clinical consequences].
Bechtel YC; Bechtel PR; Lelouët H; Choisy H; Dy NR
Therapie; 2001; 56(4):409-13. PubMed ID: 11677864
[TBL] [Abstract][Full Text] [Related]
13. Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe.
Asprodini EK; Zifa E; Papageorgiou I; Benakis A
Eur J Drug Metab Pharmacokinet; 1998; 23(4):501-6. PubMed ID: 10323334
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Tibetan medicine zuotai on the activity, protein and mRNA expression of CYP1A2 and NAT2].
Li XY; Liu YN; Li YP; Zhu JB; Yao XC; Li YF; Yang M; Yuan M; Fan XR; Yin YM
Yao Xue Xue Bao; 2014 Feb; 49(2):267-72. PubMed ID: 24761621
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase polymorphism in patients with Behçet's disease.
Aynacioglu AS; Bozkurt A; Nacak M; Kortunay S; Tunc R; Dincel A; Kayaalp SO
Eur J Clin Pharmacol; 2001 Nov; 57(9):659-62. PubMed ID: 11791896
[TBL] [Abstract][Full Text] [Related]
16. Comparison of N-acetyltransferase-2 enzyme genotype-phenotype and xanthine oxidase enzyme activity between Swedes and Koreans.
Djordjevic N; Carrillo JA; Roh HK; Karlsson S; Ueda N; Bertilsson L; Aklillu E
J Clin Pharmacol; 2012 Oct; 52(10):1527-34. PubMed ID: 22105431
[TBL] [Abstract][Full Text] [Related]
17. A population and family study of N-acetyltransferase using caffeine urinary metabolites.
Bechtel YC; Bonaiti-Pellie C; Poisson N; Magnette J; Bechtel PR
Clin Pharmacol Ther; 1993 Aug; 54(2):134-41. PubMed ID: 8354022
[TBL] [Abstract][Full Text] [Related]
18. Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype.
Selinski S; Blaszkewicz M; Lehmann ML; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Dietrich H; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Löhlein D; Weistenhöfer W; Schöps W; Hassan Rizvi SA; Aslam M; Bánfi G; Romics I; Steffens M; Ekici AB; Winterpacht A; Ickstadt K; Schwender H; Hengstler JG; Golka K
Pharmacogenet Genomics; 2011 Oct; 21(10):673-8. PubMed ID: 21750470
[TBL] [Abstract][Full Text] [Related]
19. Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping.
Wong P; Banerjee K; Massengill J; Nowell S; Lang N; Leyland-Jones B
J Immunol Methods; 2001 May; 251(1-2):1-9. PubMed ID: 11292476
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
Hein DW; Doll MA; Rustan TD; Ferguson RJ
Cancer Res; 1995 Aug; 55(16):3531-6. PubMed ID: 7627960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
